These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1514885)

  • 41. [Assessment of spasticity therapy with baclofen pump in children].
    Swierczyńska A
    Przegl Lek; 2007; 64 Suppl 2():15-7. PubMed ID: 17953273
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Continuous intrathecal infusion of baclofen. A new therapeutic method for spasticity].
    Berg-Johnsen J; Røste GK; Solgaard T; Lundar T
    Tidsskr Nor Laegeforen; 1998 Sep; 118(21):3256-60. PubMed ID: 9772811
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Obstructed catheter connection pin discovered during intrathecal baclofen pump exchange.
    Williams BS; Christo PJ
    Clin J Pain; 2009; 25(3):256-9. PubMed ID: 19333178
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety and one-year efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy.
    Hoving MA; van Raak EP; Spincemaille GH; van Kranen-Mastenbroek VH; van Kleef M; Gorter JW; Vles JS;
    Eur J Paediatr Neurol; 2009 May; 13(3):247-56. PubMed ID: 18590974
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Treatment of spasticity with intrathecal baclofen].
    Rodríguez MJ; de la Torre MR; Muñoz JL
    Rev Esp Anestesiol Reanim; 1992; 39(5):289-92. PubMed ID: 1410749
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Continuous intrathecal baclofen infusion for spasticity of cerebral origin.
    Albright AL; Barron WB; Fasick MP; Polinko P; Janosky J
    JAMA; 1993 Nov; 270(20):2475-7. PubMed ID: 8230625
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intrathecal baclofen for spasticity in cerebral palsy.
    Albright AL; Cervi A; Singletary J
    JAMA; 1991 Mar; 265(11):1418-22. PubMed ID: 1999883
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intrathecal baclofen for spastic hypertonia from stroke.
    Meythaler JM; Guin-Renfroe S; Brunner RC; Hadley MN
    Stroke; 2001 Sep; 32(9):2099-109. PubMed ID: 11546903
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Guided intrathecal baclofen administration by using soleus stretch reflex in moderate-severe spastic multiple sclerosis patients with implanted pump.
    Nielsen JF; Sinkjaer T
    Mult Scler; 2004 Oct; 10(5):521-5. PubMed ID: 15471367
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of concentration and mode of intrathecal baclofen administration on soleus H-reflex in patients with muscle hypertonia.
    Stokic DS; Yablon SA
    Clin Neurophysiol; 2012 Nov; 123(11):2200-4. PubMed ID: 22595326
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of intrathecal baclofen on voluntary motor control in spastic paresis.
    Latash ML; Penn RD; Corcos DM; Gottlieb GL
    J Neurosurg; 1990 Mar; 72(3):388-92. PubMed ID: 2303873
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Adequate dose of intrathecal baclofen therapy for spasticity].
    Wajima D; Hirabayashi H; Nishimura F; Motoyama Y; Nakase H
    No Shinkei Geka; 2011 Apr; 39(4):345-50. PubMed ID: 21447848
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term clinical, electrophysiological and urodynamic effects of chronic intrathecal baclofen infusion for treatment of spinal spasticity.
    Mertens P; Parise M; Garcia-Larrea L; Benneton C; Millet MF; Sindou M
    Acta Neurochir Suppl; 1995; 64():17-25. PubMed ID: 8748577
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of intrathecal baclofen on gait control in human hereditary spastic paraparesis.
    Dan B; Bouillot E; Bengoetxea A; Cheron G
    Neurosci Lett; 2000 Feb; 280(3):175-8. PubMed ID: 10675789
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The treatment of spasticity by intrathecal administration of baclofen: a preliminary personal experience.
    Broggi G; Servello D; Brock S; Dones I
    J Neurosurg Sci; 1993 Dec; 37(4):203-8. PubMed ID: 7931643
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prospective study on the use of bolus intrathecal baclofen for spastic hypertonia due to acquired brain injury.
    Meythaler JM; DeVivo MJ; Hadley M
    Arch Phys Med Rehabil; 1996 May; 77(5):461-6. PubMed ID: 8629922
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Botulinum toxin injections for pediatric patients with hereditary spastic paraparesis.
    Geva-Dayan K; Domenievitz D; Zahalka R; Fattal-Valevski A
    J Child Neurol; 2010 Aug; 25(8):969-75. PubMed ID: 20406997
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Objective assessment of gait after intrathecal baclofen in hereditary spastic paraplegia.
    Klebe S; Stolze H; Kopper F; Lorenz D; Wenzelburger R; Deuschl G; Volkmann J
    J Neurol; 2005 Aug; 252(8):991-3. PubMed ID: 15765194
    [No Abstract]   [Full Text] [Related]  

  • 59. Mechanical measurements of the effects of intrathecal baclofen dosage adjustments in cerebral palsy: a pilot study.
    Schmit BD; Gaebler-Spira D
    Am J Phys Med Rehabil; 2004 Jan; 83(1):33-41. PubMed ID: 14709973
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intrathecal baclofen for treatment of spasticity.
    Vanneste J; Augustijn P
    J Neurol Neurosurg Psychiatry; 1990 Aug; 53(8):721. PubMed ID: 2213058
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.